Tissue Regenix Group Plc
("Tissue Regenix" or "the Company")
Issue of Equity
The Company announces that it has today issued 500,702 ordinary shares of 0.5p each in the Company following the exercise of options by employees of the Company. The options over 190,702 shares were held under the Company's EMI scheme and 310,000 shares held under the Company's unapproved plan both of which were exercised at a price of 0.72993p per share.
The new ordinary shares will rank pari passu with existing ordinary shares and application will be made for these new ordinary shares to be admitted to trading on AIM, which is expected to occur on 29 November 2010.
Following the issue of the new ordinary shares, the Company will have a total of 469,098,605 ordinary shares of 0.5p each in issue.
Contact
Antony Odell Tissue Regenix Group plc
|
+44 (0) 20 7099 7266 |
Sarang Shah/ John Depasquale ZAI Corporate Finance Ltd
|
+44 (0) 20 7060 2220 |
Ben Atwell / John Dineen
|
+44 (0)207 831 3113 |